 Taysha Gene Therapies NASDAQ: TSHA jumped 50 overnight after Japans Astellas Pharma OTCMKTS: ALPMY bought 15 of the company and exclusive marketing rights to its genetic therapies. Taysha is working on two Adeno Associated Virus AAV therapies for genetic brain disorders. 